{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T09:50:05Z","timestamp":1786960205716,"version":"build-2736575974"},"reference-count":27,"publisher":"American Psychiatric Association Publishing","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AJP"],"published-print":{"date-parts":[[2003,7,1]]},"DOI":"10.1176\/appi.ajp.160.7.1263","type":"journal-article","created":{"date-parts":[[2003,6,29]],"date-time":"2003-06-29T18:14:13Z","timestamp":1056910453000},"page":"1263-1271","source":"Crossref","is-referenced-by-count":255,"title":["Olanzapine Versus Divalproex Sodium for the Treatment of Acute Mania and Maintenance of Remission: A 47-Week Study"],"prefix":"10.1176","volume":"160","author":[{"given":"Mauricio","family":"Tohen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence A.","family":"Ketter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Zarate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trisha","family":"Suppes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Frye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Altshuler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Zajecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie M.","family":"Schuh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard C.","family":"Risser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"230","reference":[{"key":"R1607CACHBFFH","doi-asserted-by":"crossref","unstructured":"Tohen M, Waternaux CM, Tsuang MT: Outcome in mania: a 4-year prospective follow-up of 75 patients utilizing survival analysis. Arch Gen Psychiatry 1990; 47:1106-1111","DOI":"10.1001\/archpsyc.1990.01810240026005"},{"key":"R1607CACFJFFG","unstructured":"Montgomery S, van Zwieten-Boot B, Angst J, Bowden CL, Calabrese JR, Chengappa R, Goodwin G, Lecrubier Y, Licht R, Nolen WA, Sachs G, Saint Raymond A, Storosum J, Suppes P, van Ree JM: ECNP Consensus Meeting March 2000 Nice: guidelines for investigating efficacy in bipolar disorder. Eur Neuropsychopharmacol 2001; 11:79-88"},{"key":"R1607CACBCCBH","doi-asserted-by":"crossref","unstructured":"Tohen M, Hennen J, Zarate CM Jr, Baldessarini RJ, Strakowski SM, Stoll AL, Faedda GL, Suppes T, Gebre-Medhin P, Cohen BM: Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features. Am J Psychiatry 2000; 157:220-228","DOI":"10.1176\/appi.ajp.157.2.220"},{"key":"R1607CACCAHBI","doi-asserted-by":"crossref","unstructured":"Strakowski SM, Keck PE Jr, McElroy SL, West SA, Sax KW, Hawkins JM, Kmetz GF, Upadhyaya VH, Tugrul KC, Bourne ML: Twelve-month outcome after a first hospitalization for affective psychosis. Arch Gen Psychiatry 1998; 55:49-55","DOI":"10.1001\/archpsyc.55.1.49"},{"key":"R1607CACIIIIH","doi-asserted-by":"crossref","unstructured":"Zis AP, Goodwin FK: Major affective disorder as a recurrent disease: a critical review. Arch Gen Psychiatry 1979; 36:835-839","DOI":"10.1001\/archpsyc.1979.01780080009002"},{"key":"R1607CACIIAEC","doi-asserted-by":"crossref","unstructured":"Keller MB, Lavori PW, Rice J, Coryell W, Hirschfeld RM: Differential outcome of pure manic, mixed\/cycling, and pure depressive episodes in patients with bipolar illness. JAMA 1986; 255:3138-3142","DOI":"10.1001\/jama.255.22.3138"},{"key":"R1607CACBEAHG","doi-asserted-by":"crossref","unstructured":"Bowden CL, Brugger AM, Swann AC, Calabrese JR, Janicak PG, Petty F, Dilsaver SC, David JM, Rush AJ, Small JG, Garza-Trevino ES, Risch C, Goodnick PJ, Morris DD: Efficacy of divalproex versus lithium and placebo in the treatment of mania. JAMA 1994; 271:918-924","DOI":"10.1001\/jama.271.12.918"},{"key":"R1607CACCHGJF","doi-asserted-by":"crossref","unstructured":"Pope HG Jr, McElroy SL, Keck PE Jr, Hudson JI: Valproate in the treatment of acute mania: a placebo-controlled study. Arch Gen Psychiatry 1991; 48:62-68","DOI":"10.1001\/archpsyc.1991.01810250064008"},{"key":"R1607CACJCGAF","doi-asserted-by":"crossref","unstructured":"Tohen M, Sanger TM, McElroy SL, Tollefson GD, Chengappa KNR, Daniel DG, Petty F, Centorrino F, Wang R, Grundy SL, Greaney MG, Jacobs TG, David SR, Toma V, Olanzapine HGEH Study Group: Olanzapine versus placebo in the treatment of acute mania. Am J Psychiatry 1999; 156:702-709","DOI":"10.1176\/ajp.156.5.702"},{"key":"R1607CACDCCJG","doi-asserted-by":"crossref","unstructured":"Tohen M, Jacobs TG, Grundy SL, Banov MC, McElroy SL, Janicak PG, Zhang F, Toma V, Francis BJ, Sanger TM, Tollefson GD, Breier A: Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. Arch Gen Psychiatry 2000; 57:841-849","DOI":"10.1001\/archpsyc.57.9.841"},{"key":"R1607CACEHIFC","unstructured":"Bowden CL, Calabrese JR, McElroy SL, Gyulai L, Wassef A, Petty F, Pope HG Jr, Chou JCY, Keck PE Jr, Rhodes LJ, Swann AC, Hirschfeld RMA, Wozniak PJ (Divalproex Maintenance Study Group): A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Arch Gen Psychiatry 2000; 57:481-489"},{"key":"R1607CACIHBHD","doi-asserted-by":"crossref","unstructured":"Gelenberg AJ, Kane JM, Keller MB, Lavori P, Rosenbaum JF, Cole K, Lavelle J: Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. N Engl J Med 1989; 321:1489-1493","DOI":"10.1056\/NEJM198911303212201"},{"key":"atypb1","doi-asserted-by":"crossref","unstructured":"Greil W, Ludwig-Mayerhofer W, Erazo N, Schochlin C, Schmidt S, Engel RR, Czernik A, Giedke H, M\u00fcller-Oerlinghausen B, Osterheider M, Rudolf GAE, Sauer H, Tegeler J, Wetterling T: Lithium versus carbamazepine in the maintenance treatment of bipolar disorders\u2014a randomized study. J Affect Disord 1997; 43:151-161","DOI":"10.1016\/S0165-0327(96)01427-9"},{"key":"R1607CACFCFJE","doi-asserted-by":"crossref","unstructured":"Suppes T, Webb A, Paul B, Carmody T, Kraemer H, Rush AJ: Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania. Am J Psychiatry 1999; 156:1164-1169","DOI":"10.1176\/ajp.156.8.1164"},{"key":"R1607CACGAJIC","doi-asserted-by":"crossref","unstructured":"Tohen M, Baker RW, Altshuler LL, Zarate CA, Suppes T, Ketter TA, Milton DR, Risser R, Gilmore JA, Breier A, Tollefson GA: Olanzapine versus divalproex in the treatment of acute mania. Am J Psychiatry 2002; 159:1011-1017","DOI":"10.1176\/appi.ajp.159.6.1011"},{"key":"R1607CACGCJJD","doi-asserted-by":"crossref","unstructured":"Young RC, Biggs JT, Ziegler VE, Meyer DA: A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133:429-435","DOI":"10.1192\/bjp.133.5.429"},{"key":"R1607CACHCJCH","doi-asserted-by":"crossref","unstructured":"Hamilton M: Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967; 6:278-296","DOI":"10.1111\/j.2044-8260.1967.tb00530.x"},{"key":"R1607CACJEBIH","doi-asserted-by":"crossref","unstructured":"Spearing M, Post R, Leverich G, Brandt D, Nolen W: Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI for bipolar disorder: the CGI-BP. Psychiatry Res 1997; 73:159-171","DOI":"10.1016\/S0165-1781(97)00123-6"},{"key":"R1607CACFGEIJ","doi-asserted-by":"crossref","unstructured":"Kay SR, Fiszbein A, Opler LA: The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13:261-276","DOI":"10.1093\/schbul\/13.2.261"},{"key":"R1607CACCICJB","doi-asserted-by":"crossref","unstructured":"Tohen M, Stoll AL, Strakowski SM, Faedda GL, Mayer PV, Goodwin DC, Kolbrener ML, Madigan AM: The McLean First-Episode Psychosis Project: six-month recovery and recurrence outcome. Schizophr Bull 1992; 18:273-282","DOI":"10.1093\/schbul\/18.2.273"},{"key":"R1607CACECGGA","doi-asserted-by":"crossref","unstructured":"Frank E, Prien RF, Jarrett RB, Keller MB, Kupfer DJ, Lavori PW, Rush AJ, Weissman MM: Conceptualization and rationale for consensus definitions of terms in major depressive disorder: remission, recovery, relapse, and recurrence. Arch Gen Psychiatry 1991; 48:851-855","DOI":"10.1001\/archpsyc.1991.01810330075011"},{"key":"R1607CACBABFA","doi-asserted-by":"crossref","unstructured":"Simpson GM, Angus JWS: A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 1970; 212:11-19","DOI":"10.1111\/j.1600-0447.1970.tb02066.x"},{"key":"R1607CACHGJJD","doi-asserted-by":"crossref","unstructured":"Barnes TRE: A rating scale for drug-induced akathisia. Br J Psychiatry 1989; 154:672-676","DOI":"10.1192\/bjp.154.5.672"},{"key":"R1607CACJJEIE","doi-asserted-by":"crossref","unstructured":"Zajecka JM, Weisler R, Sachs G, Swann AC, Wozniak P, Somerville KW: A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder. J Clin Psychiatry 2002; 63:1148-1155","DOI":"10.4088\/JCP.v63n1210"},{"key":"R1607CACEFGFD","doi-asserted-by":"crossref","unstructured":"Kinon BJ, Basson B, Gilmore JA, Tollefson GD: Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia. J Clin Psychiatry 2001; 62:92-100","DOI":"10.4088\/JCP.v62n0204"},{"key":"R1607CACGBGDD","doi-asserted-by":"crossref","unstructured":"Biton V, Mirza W, Montouris G, Vuong A, Hammer AE, Barrett PS: Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy. Neurology 2001; 56:172-177","DOI":"10.1212\/WNL.56.2.172"},{"key":"R1607CACIFBHA","doi-asserted-by":"crossref","unstructured":"Czekalla J, Beasley CJ, Dellva M, Berg PH, Grundy S: Analysis of the QTc interval during olanzapine treatment of patients with schizophrenia and related psychosis. J Clin Psychiatry 2001; 62:191-198","DOI":"10.4088\/JCP.v62n0310"}],"container-title":["American Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.160.7.1263","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T18:37:55Z","timestamp":1721846275000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.160.7.1263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,7,1]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2003,7,1]]}},"alternative-id":["10.1176\/appi.ajp.160.7.1263"],"URL":"https:\/\/doi.org\/10.1176\/appi.ajp.160.7.1263","relation":{},"ISSN":["0002-953X","1535-7228"],"issn-type":[{"value":"0002-953X","type":"print"},{"value":"1535-7228","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,7,1]]}}}